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Mosquito-borne diseases are an increasing global health challenge,
threatening over 40% of the world’s population. Despite major advances
in malaria control since 2000, recent progress has stalled. Additionally, the
risk of Aedes-borne arboviruses is rapidly growing, with the unprecedented
spread of dengue and chikungunya viruses, outbreaks of yellow fever and
the 2015 epidemic of Zika virus in Latin America. To counteract this growing
problem, diverse and innovative mosquito control technologies are currently
under development. Conceptually, these span an impressive spectrum of
approaches, from invasive transgene cassettes with the potential to crash
mosquito populations or reduce the vectorial capacity of a population, to
low-cost alterations in housing design that restrict mosquito entry. This
themed issue will present articles providing insight into the breadth of
mosquito control research, while demonstrating the requirement for an
interdisciplinary approach. The issue will highlight mosquito control
technologies at varying stages of development and includes both opinion
pieces and research articles with laboratory and field-based data on control
strategy development.
This article is part of the theme issue ‘Novel control strategies for
mosquito-borne diseases’.1. Introduction
Diseases transmitted by mosquitoes are of global importance. Malaria is
responsible for more than 400 000 deaths each year, and dengue, yellow fever,
chikungunya and Zika have caused severe disease outbreaks in many urban
areas [1–3]. Approximately half of the world’s population is expected to be at
the risk of arbovirus transmission by 2050 [4]. The principal methods available
for reducing the public health burden of most mosquito-borne diseases are
vector-based interventions. Prior to the development of insecticides, these inter-
ventions relied on environmental management and focused on the removal of
mosquito breeding sites and the improvement of housing with screens to
prevent access of mosquitoes through doors and windows. Following World
War II, DDT, dieldrin and other compounds were produced for indoor and
outdoor use, and insecticides were eventually incorporated into bed nets [5].
The use of long-lasting insecticidal nets (LLINs) and indoor residual spray-
ing (IRS) accounted for most of the unprecedented reductions in malaria
burden achieved in the twenty-first century [6]. However, LLINs and IRS are
not sufficient to eliminate malaria transmission in many settings because of
operational constraints or because the mosquito vectors are not susceptible to
the insecticides used [7]. Some species naturally avoid contact with insecticides,
but there is also evidence for the emergence and spread of resistance through
metabolic detoxification, and this has driven the need to develop LLINs
with synergists and additional compounds for use in IRS [8]. Despite these
developments and the sustained efforts to control mosquitoes, epidemics and
the spread of mosquito-borne diseases continue to threaten the health of billions




2malaria, vector control products have been used to limit the
transmission of the disease agents transmitted by Aedes mos-
quitoes, and again there is concern about the continued use of
existing tools against these mosquitoes. Larviciding or space
spraying of pyrethroids and organophosphates is challenged
by high costs, low community adoption and slow operational
implementation, and insecticide resistance in Aedes is now
widespread [10,11].
The recent coronavirus outbreak has further highlighted
the need for new tools, particularly those that are less
labour intensive to implement. Mitigation strategies to curtail
the transmission of SARS-CoV-2 have been introduced in
many countries around the world and are expected to have
averted millions of SARS-CoV-2 infections [12,13], but
are disruptive to vector-borne disease prevention activities.
While the World Health Organization (WHO) has urged
countries not to scale back their planned malaria prevention,
diagnostic and treatment activities [14], bed net distribu-
tion programmes and IRS could be reduced or cancelled
in some areas: bed nets are typically distributed centrally
from distribution points, which may be cancelled or poorly
attended because of societal measures against COVID-19,
and for IRS to continue, spray operators need additional
personal protective equipment and training. Modelling
studies suggest that, in sub-Saharan Africa, a halt to such
activities could lead to the malaria burden in 2020 ultimately
being double that of 2019 [15]. Mass drug administration of
malaria chemoprevention could mitigate excess malaria
deaths during the COVID-19 epidemic, but other tools
covered in this theme issue may also find particular value
in the current climate.
The process for developing novel interventions is multi-
staged. It begins with defining the target product profile,
which outlines the features and performance targets of the
intended vector control tool, and the mode of action [16].
Proof of concept is demonstrated by conducting phase I
studies in the laboratory, to explore the effect of the tool
and duration of efficacy, and phase II studies in small-
scale field or semi-field conditions. These confirm product
performance and user acceptability in specific settings and
typically only have entomological outcomes, such as human
vector contact, without determining any direct impacts on
disease transmission.
The WHO requires novel vector control products falling
outside an established intervention class to provide epide-
miological evidence of public health impact [17]. The
efficacy of a vector control tool implemented under optimal
conditions can be assessed through a phase III field study
that includes epidemiological outcomes. Based on the results
of phase III trials, WHO will make recommendations for
pilot implementation to assess the effectiveness of the
vector control tool when it is delivered and used under
‘real-world’ conditions. Once the public health value has
been confirmed, and policy recommendations have been
established, a product can be given a WHO product listing
provided that efficacy, safety and quality standards are
met [18].
If control and elimination targets for malaria and other
mosquito-borne neglected tropical diseases are to be met
over the next decade, vector control interventions need to
play an increasingly prominent role. In this theme issue,
we present current studies and opinions on novel control
strategies for mosquito-borne diseases.2. Use of randomized controlled trials and
mathematical modelling
Rigorous field trials are required to evaluate novel vector
control tools, but financial, temporal and other resource
restrictions may prevent such studies being conducted and
stop valuable vector control tools from being rolled out.
Where there are established links between entomological
and epidemiological indicators, it has been argued that new
products within the same product category may be rapidly
evaluated through smaller scale experiments without the
need to repeat lengthy and expensive randomized controlled
trials (RCTs) [16]. Further, mathematical modelling that
can translate experimental hut data to product efficacies, or
relate entomological outcomes to epidemiological outcomes,
may reduce the need for phase III studies in some instances.
In this theme issue, Hellewell et al. [19] discuss the role of
modelling in predicting the impact of using the mass deploy-
ment of spatial repellent emanators, containing transfluthrin,
together with LLINs to target outdoor as well as indoor
transmission of malaria. Using entomological field data to
parameterize the models, the resulting simulations for all of
the different scenarios tested indicated that emanators pro-
vided an additional benefit over LLINs alone. Although the
modelling results are encouraging, the authors conclude that
a better understanding of aspects of emanators and human
behaviour is required to further inform predications of impact.
Mathematical approaches can also be used to help decide
which tools to use where. For example, there is a marked
difference in IRS product efficacy in settings with different
mosquito populations. By analysing mosquito mortality,
blood-feeding and deterrence data, transmission dynamics
mathematical modelling can be employed to predict the
public health impact of different IRS insecticides in areas
with different levels of LLIN coverage and pyrethroid resist-
ance [20]. Such approaches may bypass the need for multiple
RCTs with new IRS products and provide a framework to
allow decision makers to evaluate IRS cost-effectiveness
based on local entomology, local epidemiology, product
price and budget.
However, when possible, RCTs offer the most robust, and
least biased, method to estimate whether an intervention will
be effective, as discussed by Jones et al. [21]. Their paper
focuses on the benefits and challenges of using island settings
to conduct cluster-randomized trials, in order to evaluate
interventions for the control of vector-borne diseases, and
the Bijagós archipelago of Guinea-Bissau is used as a case
study. The islands are co-endemic for malaria and neglected
tropical diseases, such as lymphatic filariasis, scabies and
soil-transmitted helminths, and have been targeted for a
mass drug administration programme using ivermectin.
Ivermectin operates as a systemic insecticide, or endectocide,
that can reduce the survivorship of Anopheles gambiae mosqui-
toes and impair the development of Plasmodium falciparum
[22–24]. It could be administered to eligible members of an
at-risk community as a complementary tool for vector control,
but there is also the possibility of controlling human vector-
borne diseases through the treatment of livestock, as explored
by Chaccour [25]. This approach would be most impactful
against residual malaria in areas where malaria transmission is
driven by zoophagic vectors. It is supported by modelling and
semi-field data on the transmission of malaria in some settings,




33. Household-level vector control tools
Residual transmission ofmalaria is defined as the persistence of
transmission following the implementation in time and space of
awidelyeffectivemalaria programme.While insecticide-treated
bed nets, IRS and prompt treatment of clinical malaria cases
with artemisinin-based combination therapy are estimated to
have been the main contributors to the reduction in infection
prevalence in endemic Africa [6], socioeconomic development
and improvements to housing are also expected to have pro-
moted reductions in transmission in some settings [28,29].
Indeed, improved housing should be considered a promising
intervention for malaria control, and there are opportunities to
modify house designs to prevent mosquito house entry and
reduce mosquito production around the home.
Lindsay et al. [30] explore relatively simple changes to the
built environment, including the installation of tight-fitting
screened doors, the closing or screening of eaves and replace-
ment of thatched roofs with roofs made from solid materials,
such as metal or tile. An important message is to combine a
package of interventions for maximum impact. An example of
the impact of such an approach comes from a study in
Burkina Faso, which indicated that children living in houses
with mud roofs had a significantly higher risk of getting
P. falciparum infection compared to those living in iron-sheet
roofed houses [31]. This suggests that modifications to roof con-
struction may help to reduce the burden of malaria through
reducing exposure to mosquitoes. However, the increased
indoor temperatures associatedwithmetal roofsmayencourage
some people to sleep outside during hot nights [32]. Changes in
roof materials should, therefore, be coupled with other features
to increase ventilation, whichwill not only bring down internal
temperatures but also prevent the concentration of carbon
dioxide that acts as an attractant to mosquitoes [33].
Further research is needed in this emerging field, and many
knowledge gaps remain to be filled. Among these is a better
understanding of how mosquitoes enter buildings. In this
issue, Barreaux et al. [34] consider the role of both human and
mosquito behaviouron the efficacyof a house-based intervention
designed to reducemalaria transmissionbypreventingmosquito
access through windows and eaves. PVC eave tubes fitted with
electrostatic netting containing an insecticide-treated screen
were inserted into the closed eaves of houses in a study village
in Cote d’Ivoire. The houses were also fitted with window
screens. Monitoring of the treated houses in the study villages
revealed that doors and windows were both left open for large
parts of the evening and morning by the household residents,
despite the modifications made to make them more mosquito
proof. However, studies with experimental houses showed that,
even when doors and windows were open in line with normal
householder behaviour, the screening and eave tube treatment
still led to significant reductions in mosquitoes indoors relative
a standard control houses. The results of a large scale cluster-
randomized trial investigating the epidemiological impact of
the window screens and eaves tubes [35] are keenly awaited.4. Biotechnological control of mosquitoes
Further to these relatively simple mosquito control strategies,
new biotechnologically advanced methods that build upon
their successful use against agricultural pests are being
developed for use against vectors that transmit agents of
human diseases. These technologies, including the use ofgenetic modification and Wolbachia endosymbionts, have
been worked on for the last 20 years or so, and show great
promise. Despite the exciting possibilities, there remain some
important challenges to their widespread introduction, such
as regulatory considerations, logistical difficulties and techni-
cal issues, as well as social and cultural issues, which can
influence acceptance of these methods.
One technical challenge, in particular, is introduced byLeft-
wich et al. [36]. Releasingmodified versions of an insect species
is likely to result in mating occurring with wild species within
the target area. This could lead to DNA from modified insects
entering into the wild population if mating is successful
betweenmodified and unmodified insects. The authors discuss
how background genetics may affect genetic pest management
and the importance of strain selection. They conclude that
introgression is likely to be harmless and could even provide
additional benefits to a release programme.
Gene drive, whereby a genetic modification is intended to
spread through a population at higher rates of inheritance than
normal, is another promising new technology for the control
ofmosquito-bornediseases. Recent years have seen the develop-
ment of gene-drive technologies in the primary sub-Saharan
malaria vector, An. gambiae. Depending on design, the gene-
drive system could have the capacity to either suppress a wild
mosquito population or reduce its transmission competency
by spreading genes that interfere with parasite development.
In this issue, Dr TonyNolan provides an overview of recent pro-
gress in the development of gene- drive systems in Anopheles
mosquitoes and discusses the major limitations and challenges
facing their deployment in the field [37].Adelman et al. [38] high-
light a particular issue with translating gene-drive technologies
developed in the laboratory into practice in the field, caused
by difficulties in removing gene-drive transgenes from nature.
The authors present the possibility of including self-elimination
mechanisms into homing-based gene-drive transgenes and
suggest that this system, even if acting at a rate of just 10%,
would be enough to overcome the problem, tolerating substan-
tial rates of failure. This self-elimination technology may also
facilitate field-based testing of gene drives by establishing strict
time limits on the existence of gene-drive transgenes in nature.
Genetically modified control approaches share commonal-
ities with Wolbachia-based population replacement strategies
[39]. Various strains of the bacterial endosymbiont Wolbachia
have now been transferred from their native host species into
Aedes aegypti, where they have the capacity to block the trans-
mission of dengue and Zika viruses. Several field studies have
documented the release ofWolbachia-infectedAe. aegypti, which
are expected to spread from release sites and become fixed in
the target population, providing a viable strategy for arbovirus
control through themodification ofwildmosquito populations
[40,41]. The long-term success of this approach depends on the
capacity for theWolbachia strain to maintain virus transmission
blocking over time frames of many years. Here, Ahmed et al.
[42] test the capacity of a field-adapted wAlbB-carrying Ae.
aegypti strain collected from release sites in Kuala Lumpur,
Malaysia, to block dengue virus transmission. The authors
report that virus blocking by wAlbB was not compromised
by 18 months of Wolbachia-host coevolution in the field. The
wAlbB strain also retained the ability to induce complete uni-
directional cytoplasmic incompatibility, which is vital for
maintenance at a high population infection frequency. The
results provide additional support for the continued scale-up




4As with genetic modification, population replacement
approaches with Wolbachia are dependent on field releases of
mosquitoes. Indeed, release programmes must be sufficiently
large to ensure that a threshold prevalence is exceeded, other-
wise theWolbachia infection will probably be lost once releases
stop [43]. It has, therefore, been necessary to develop suitable
rear and release protocols for these mosquitoes. Similarly,
although typically on a much larger scale, the sterile insect
technique (SIT) involves the mass-rearing of a target species,
their sterilization (usually by exposure to radiation or chemos-
terilants) and their release into a wild population. The
subsequent induction of infertility in the wild population
reduces its reproductive potential, and if releases are main-
tained over sufficient generations, a target population may
be suppressed or even eliminated [44]. SIT is most effective
and economical when the sterile release populations consist
solely of males. Mechanisms for sexing mosquitoes have tra-
ditionally relied on mechanical sorting that exploits natural
size dimorphisms between male and female pupae. However,
novel genetic methods that use sex-linked markers may be
able to increase the accuracy and efficiency of high throughput
sex-sorting. In this issue, Augustinos et al. [45] report the
generation ofAe. aegypti strains carrying chromosomal translo-
cations that link eye pigmentation markers with theAe. aegypti
male sex-determining locus. In combination with classical
rearing methods that help maintain the integrity of the
sexing strains, the authors present a proof-of-principle
camera-based mass-rearing system that detects eye colour
differences in pupae and sorts males from females, providing
foundational steps towards a possible high accuracy and
high throughput mass-rearing system.5. The future of vector control
Further active and exciting areas of research on potential new
tools for vector control include the development of targeted
sugar baits, which kill mosquitoes that are attracted to and feed
on toxic sugar meals sprayed on plants or used in bait stations
[46]. Transgenic fungi canalsobedisseminated frombait stations
and have shown very promising results in semi-field trials [47].Mosquito traps have been used for decades for purposes of
surveillance, but are also considered as tools for mosquito con-
trol provided that they are sufficiently specific in attracting
target species. This can be achieved through a combination of
attractant cues, and relies on our understanding ofmosquito be-
haviour. Host-seeking behaviour is activated by the synergistic
effect of carbon dioxide and the volatile odour compounds pro-
duced by the host’s body and microbiota. Because body odour
is affected by host genetics, there is a high degree of heterogen-
eity in mosquito attractiveness towards different people.
Martinez et al. [48] provide an in-depth review of the biological
factors that influence a person’s attractiveness to mosquitoes
and discuss the potential role that volatile odour compounds
could have in future vector control efforts.
Finally, there are tools that are in earlier stages of
development, including acoustic larvicides [49], RNAi-based
bioinsecticides [50] and technologies for improving the incor-
poration of insecticides and repellents into clothing and other
materials [51]. We eagerly anticipate results from studies with
these and other approaches.
Once any new technology is implemented, monitoring of
its success in reducing the disease prevalence is a logistical
challenge. An alternative method to screening human popu-
lations is xenomonitoring, wherein mosquito surveillance is
used as a proxy for human infection. Cameron & Ramesh
[52] discuss how this approach offers logistical benefits
for predicting disease transmission in humans and the diffi-
culties that remain in achieving standardization across
different diseases and countries.
Most vector-borne diseases can be prevented by vector con-
trol, if it is implementedwell [53]. The alternative strategies that
are becoming available, and which are covered in this theme
issue, will provide additional options for the control of mos-
quito-borne diseases and may add value to existing strategies.Data accessibility. This article has no additional data.
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